Saiakuntzen zerrenda


The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Wilmer Eye Institute, Baltimore, Maryland, United States Retina Foundation of the Southwest, Dallas, Texas, United States Universit ts-Augenklinik Bonn, Bonn, Germany Center for Opthalmic Research, University of Tuebingen, Tuebingen, Germany Moorfields Eye Hospital, London, United Kingdom
Ver informe

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT 1

Tratamiento

MEDICAMENTO: Zimura Other: Sham

Localizaciones

Retinal Consultants of Arizona, Phoenix, Arizona, United States Jules Stein Eye Institute/ David Geffen School of Medicine, Los Angeles, California, United States VitreoRetinal Associates, Gainesville, Florida, United States Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, United States Ophthalmic Consultants of Boston, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States Retina Center P.A., Minneapolis, Minnesota, United States Oregon Health & Science University, Portland, Oregon, United States Mid Atlantic Retina, Philadelphia, Pennsylvania, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States and 30 more
Ver informe

Phase I/IIA Study of SAR422459 in Participants With Stargardt’s Macular Degeneration

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: SAR422459

Localizaciones

Investigational Site Number 840002, Miami, Florida, United States Investigational Site Number 840005, Iowa City, Iowa, United States Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 840004, Houston, Texas, United States Investigational Site Number 250001, Paris, France
Ver informe

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: Long term follow up in all patients who received SAR422459 in previous study TDU13583

Localizaciones

Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 250001, Paris, France
Ver informe

Safety and Efficacy of Emixustat in Stargardt Disease

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: Emixustat MEDICAMENTO: Placebo

Localizaciones

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States UCSF Dept. of Ophthalmology, San Francisco, California, United States Emory University, Atlanta, Georgia, United States The Wilmer Eye Institute Johns Hopkins University, Baltimore, Maryland, United States University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States Mayo Clinic Rochester, Rochester, Minnesota, United States Duke Eye Center, Durham, North Carolina, United States Casey Eye Institute - OHSU, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah John Moran Eye Center, Salt Lake City, Utah, United States and 19 more
Ver informe

Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Kellogg Eye Center, Ann Arbor, Michigan, United States
Ver informe